Chugai Pharmaceutical (OTCMKTS:CHGCY) Earns Outperform Rating from Analysts at Sanford C. Bernstein

Sanford C. Bernstein assumed coverage on shares of Chugai Pharmaceutical (OTCMKTS:CHGCYGet Rating) in a research report released on Tuesday, The Fly reports. The brokerage issued an outperform rating on the stock.

Chugai Pharmaceutical Trading Up 0.2 %

Shares of CHGCY opened at $13.43 on Tuesday. Chugai Pharmaceutical has a twelve month low of $10.99 and a twelve month high of $14.86. The stock’s 50 day moving average is $12.71 and its two-hundred day moving average is $12.75. The firm has a market capitalization of $44.18 billion, a PE ratio of 15.26 and a beta of 0.58.

Chugai Pharmaceutical Company Profile

(Get Rating)

Chugai Pharmaceutical Co, Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan.

See Also

The Fly logo

Receive News & Ratings for Chugai Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chugai Pharmaceutical and related companies with's FREE daily email newsletter.